Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.
2.

Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy.

Miller MA, Louie T, Mullane K, Weiss K, Lentnek A, Golan Y, Kean Y, Sears P.

BMC Infect Dis. 2013 Mar 25;13:148. doi: 10.1186/1471-2334-13-148.

4.

Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics.

van Werkhoven CH, van der Tempel J, Jajou R, Thijsen SF, Diepersloot RJ, Bonten MJ, Postma DF, Oosterheert JJ.

Clin Microbiol Infect. 2015 Aug;21(8):786.e1-8. doi: 10.1016/j.cmi.2015.04.005. Epub 2015 Apr 16.

5.

Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections.

McGregor JC, Perencevich EN, Furuno JP, Langenberg P, Flannery K, Zhu J, Fink JC, Bradham DD, Harris AD.

J Clin Epidemiol. 2006 Dec;59(12):1266-73. Epub 2006 Aug 10.

PMID:
17098569
6.

National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.

Jarvis WR, Schlosser J, Jarvis AA, Chinn RY.

Am J Infect Control. 2009 May;37(4):263-70. doi: 10.1016/j.ajic.2009.01.001. Epub 2009 Mar 10.

PMID:
19278754
7.

Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.

Carignan A, Allard C, P├ępin J, Cossette B, Nault V, Valiquette L.

Clin Infect Dis. 2008 Jun 15;46(12):1838-43. doi: 10.1086/588291.

PMID:
18462108
8.

High Horn's index score predicts poor outcomes in patients with Clostridium difficile infection.

Arora V, Kachroo S, Ghantoji SS, Dupont HL, Garey KW.

J Hosp Infect. 2011 Sep;79(1):23-6. doi: 10.1016/j.jhin.2011.04.027. Epub 2011 Jun 22.

PMID:
21700363
9.

A prospective cohort study on hospital mortality due to Clostridium difficile infection.

Wenisch JM, Schmid D, Tucek G, Kuo HW, Allerberger F, Michl V, Tesik P, Laferl H, Wenisch C.

Infection. 2012 Oct;40(5):479-84. doi: 10.1007/s15010-012-0258-1. Epub 2012 Apr 17.

PMID:
22527876
10.

Development and validation of a recurrent Clostridium difficile risk-prediction model.

Zilberberg MD, Reske K, Olsen M, Yan Y, Dubberke ER.

J Hosp Med. 2014 Jul;9(7):418-23. doi: 10.1002/jhm.2189. Epub 2014 Apr 4.

PMID:
24700708
11.

Hospital-acquired Clostridium difficile infection: determinants for severe disease.

Wenisch JM, Schmid D, Kuo HW, Simons E, Allerberger F, Michl V, Tesik P, Tucek G, Wenisch C.

Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1923-30. doi: 10.1007/s10096-011-1522-5. Epub 2011 Dec 31.

PMID:
22210266
12.

Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.

Harpe SE, Inocencio TJ, Pakyz AL, Oinonen MJ, Polk RE.

Pharmacotherapy. 2012 Aug;32(8):744-54. doi: 10.1002/j.1875-9114.2012.01160.x.

PMID:
23307522
13.

Monitoring Clostridium difficile infection in an acute hospital: prevalence or incidence studies?

Lavan AH, McCartan DP, Downes MM, Hill AD, Fitzpatrick F.

Ir J Med Sci. 2012 Sep;181(3):315-20. doi: 10.1007/s11845-011-0798-x. Epub 2012 Feb 15.

PMID:
22350440
14.

Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.

Pakyz A, Carroll NV, Harpe SE, Oinonen M, Polk RE.

Pharmacotherapy. 2011 Jun;31(6):546-51. doi: 10.1592/phco.31.6.546.

PMID:
21923438
15.

Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review.

Bloomfield MG, Sherwin JC, Gkrania-Klotsas E.

J Hosp Infect. 2012 Sep;82(1):1-12. doi: 10.1016/j.jhin.2012.05.008. Epub 2012 Jun 22. Review.

PMID:
22727824
16.

Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection.

Kassam Z, Cribb Fabersunne C, Smith MB, Alm EJ, Kaplan GG, Nguyen GC, Ananthakrishnan AN.

Aliment Pharmacol Ther. 2016 Mar;43(6):725-33. doi: 10.1111/apt.13546. Epub 2016 Feb 5.

17.

A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.

Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL.

J Hosp Infect. 2008 Oct;70(2):142-7. doi: 10.1016/j.jhin.2008.06.026. Epub 2008 Aug 23.

PMID:
18723249
18.

Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting.

Dalton BR, Lye-Maccannell T, Henderson EA, Maccannell DR, Louie TJ.

Aliment Pharmacol Ther. 2009 Mar 15;29(6):626-34. doi: 10.1111/j.1365-2036.2008.03924.x. Epub 2008 Dec 19.

19.

Electronic health record-based detection of risk factors for Clostridium difficile infection relapse.

Hebert C, Du H, Peterson LR, Robicsek A.

Infect Control Hosp Epidemiol. 2013 Apr;34(4):407-14. doi: 10.1086/669864. Epub 2013 Feb 13.

PMID:
23466915
20.

Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study.

Kim YS, Han DS, Kim YH, Kim WH, Kim JS, Kim HS, Kim HS, Park YS, Song HJ, Shin SJ, Yang SK, Ye BD, Eun CS, Lee KM, Lee SH, Jang BI, Jung SA, Cheon JH, Choi CH, Huh KC.

Epidemiol Infect. 2013 Jan;141(1):189-94. doi: 10.1017/S0950268812000581. Epub 2012 Apr 12.

PMID:
22717061

Supplemental Content

Support Center